This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 May:20 Suppl 4:76-8.

doi: 10.1093/annonc/mdp135.

Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

A Horwich¹, C Parker, V Kataja; ESMO Guidelines Working Group

Affiliations

PMID: 19454471
DOI: 10.1093/annonc/mdp135

Review

Prostate cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

A Horwich et al. Ann Oncol. 2009 May.

. 2009 May:20 Suppl 4:76-8.

doi: 10.1093/annonc/mdp135.

Authors

A Horwich¹, C Parker, V Kataja; ESMO Guidelines Working Group

Affiliation

¹ Department of Clinical Oncology, Royal Marsden Hospital, Sutton, UK.

PMID: 19454471
DOI: 10.1093/annonc/mdp135

No abstract available

PubMed Disclaimer

Similar articles

Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Chan AT, Felip E; ESMO Guidelines Working Group. Chan AT, et al. Ann Oncol. 2009 May;20 Suppl 4:123-5. doi: 10.1093/annonc/mdp150. Ann Oncol. 2009. PMID: 19454431 Review. No abstract available.
Anal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Glynne-Jones R, Northover J, Oliveira J; ESMO Guidelines Working Group. Glynne-Jones R, et al. Ann Oncol. 2009 May;20 Suppl 4:57-60. doi: 10.1093/annonc/mdp129. Ann Oncol. 2009. PMID: 19454464 Review. No abstract available.
Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Glimelius B, Oliveira J; ESMO Guidelines Working Group. Glimelius B, et al. Ann Oncol. 2009 May;20 Suppl 4:54-6. doi: 10.1093/annonc/mdp128. Ann Oncol. 2009. PMID: 19454463 Review. No abstract available.
Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Cascinu S, Jelic S; ESMO Guidelines Working Group. Cascinu S, et al. Ann Oncol. 2009 May;20 Suppl 4:37-40. doi: 10.1093/annonc/mdp123. Ann Oncol. 2009. PMID: 19454458 Review. No abstract available.
Gastric cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Jackson C, Cunningham D, Oliveira J; ESMO Guidelines Working Group. Jackson C, et al. Ann Oncol. 2009 May;20 Suppl 4:34-6. doi: 10.1093/annonc/mdp122. Ann Oncol. 2009. PMID: 19454457 Review. No abstract available.

See all similar articles

Cited by

Profiling of the calcitonin-calcitonin receptor axis in primary prostate cancer: clinical implications and molecular correlates.
Thakkar A, Bijnsdorp IV, Geldof AA, Shah GV. Thakkar A, et al. Oncol Rep. 2013 Sep;30(3):1265-74. doi: 10.3892/or.2013.2583. Epub 2013 Jul 2. Oncol Rep. 2013. PMID: 23820954 Free PMC article.
Prostate Cancer Therapy Using Docetaxel and Formononetin Combination: Hyaluronic Acid and Epidermal Growth Factor Receptor Targeted Peptide Dual Ligands Modified Binary Nanoparticles to Facilitate the in vivo Anti-Tumor Activity.
Dong Z, Wang Y, Guo J, Tian C, Pan W, Wang H, Yan J. Dong Z, et al. Drug Des Devel Ther. 2022 Aug 11;16:2683-2693. doi: 10.2147/DDDT.S366622. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 35983428 Free PMC article.
Use of Biomarkers in Screening for Cancer.
Duffy MJ. Duffy MJ. EJIFCC. 2010 Mar 25;21(1):1-12. eCollection 2010 Mar. EJIFCC. 2010. PMID: 27683350 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information